 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Indoco announced today that its subsidiary company, Indoco Remedies UK Limited, officially launched Ticagrelor film-coated tablets 90mg in the United Kingdom on June 2, 2025. This significant addition to Indoco's portfolio will be marketed and distributed by Clarity Pharma, across the United Kingdom.
Ticagrelor film-coated tablets are indicated to reduce the chances of heart attack, stroke, myocardial infarction (MI) or diseases related to the heart or blood vessels.
"This development underscores our commitment to bringing high quality, life-saving treatmentsto patients in the UK", said Ms. Aditi Kare Panandikar, Managing Director, Indoco Remedies Ltd.
Shares of Indoco Remedies Limited was last trading in BSE at Rs. 258.90 as compared to the previous close of Rs. 250.30. The total number of shares traded during the day was 3198 in over 233 trades.
The stock hit an intraday high of Rs. 260.20 and intraday low of 249.05. The net turnover during the day was Rs. 806731.00.